微信小陈
微信小章
产品简介
购买须知
| 产品名称： | Tetragenococcus halophilus (Mees) Collins et al. |
|---|---|
| 商品货号： | TS207211 |
| Deposited As： | Pediococcus halophilus Mees |
| Strain Designations： | FERM-P 1414 |
| Application： | Produces protein hydrolysates |
| Biosafety Level： | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Disclosure： | This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC. |
| Preceptrol®： | no |
| Type Strain： | no |
| Medium： | ATCC® Medium 977: Sodium acetate medium I |
| Growth Conditions： | Temperature: 30.0°C |
| Name of Depositor： | Kikkoman Shioyu Co., Ltd. |
| U.S. Patent Number： | |
| References： | Yokotsuka T, et al. Process for producing protein hydrolyzate. US Patent 3,932,671 dated Jan 13 1976 |